Table of Content


Chapter 1. Global Anti-inflammatory Peptides Market Executive Summary
1.1. Global Market Size & Forecast (2022–2032)
1.2. Regional Summary
1.3. Segmental Summary
?1.3.1. By Mechanism of Action
?1.3.2. By Indication
?1.3.3. By Source
?1.3.4. By Route of Administration
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendations & Conclusion
Chapter 2. Global Anti-inflammatory Peptides Market Definition and Research Assumptions
2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
?2.3.1. Inclusion & Exclusion
?2.3.2. Limitations
?2.3.3. Supply Side Analysis
??2.3.3.1. Infrastructure & Capacity
??2.3.3.2. Regulatory Environment
??2.3.3.3. Manufacturing Complexity
??2.3.3.4. Economic Viability (Provider’s Perspective)
?2.3.4. Demand Side Analysis
??2.3.4.1. Disease Prevalence & Unmet Needs
??2.3.4.2. Payer & Reimbursement Trends
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates
Chapter 3. Global Anti-inflammatory Peptides Market Dynamics
3.1. Market Drivers
?3.1.1. Rising Incidence of Autoimmune and Inflammatory Diseases
?3.1.2. Advances in Peptide Engineering and Delivery Technologies
?3.1.3. Shift Toward Targeted, Biocompatible Therapeutics
3.2. Market Challenges
?3.2.1. Peptide Stability and Degradation Issues
?3.2.2. High Manufacturing and Scale-Up Costs
?3.2.3. Regulatory and Clinical Trial Complexities
3.3. Market Opportunities
?3.3.1. Growth of Biosourced and Microbial Peptides
?3.3.2. AI-Driven Peptide Discovery Platforms
?3.3.3. Expansion of Oral and Topical Delivery Formats
Chapter 4. Global Anti-inflammatory Peptides Market Industry Analysis
4.1. Porter’s Five Forces
?4.1.1. Bargaining Power of Suppliers
?4.1.2. Bargaining Power of Buyers
?4.1.3. Threat of New Entrants
?4.1.4. Threat of Substitutes
?4.1.5. Competitive Rivalry
4.2. PESTEL Analysis
?4.2.1. Political
?4.2.2. Economic
?4.2.3. Social
?4.2.4. Technological
?4.2.5. Environmental
?4.2.6. Legal
4.3. Top Investment Opportunities
4.4. Winning Market Strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspectives
4.7. Analyst Recommendations & Conclusion
Chapter 5. Global Anti-inflammatory Peptides Market Size & Forecasts by Mechanism of Action (2022–2032)
5.1. Segment Dashboard
5.2. NF-?B Inhibition: Revenue Trend Analysis, 2022 & 2032
5.3. JAK/STAT Inhibition: Revenue Trend Analysis, 2022 & 2032
5.4. Interleukin Inhibition: Revenue Trend Analysis, 2022 & 2032
5.5. TNF-? Inhibition: Revenue Trend Analysis, 2022 & 2032
Chapter 6. Global Anti-inflammatory Peptides Market Size & Forecasts by Indication (2022–2032)
6.1. Segment Dashboard
6.2. Rheumatoid Arthritis: 2022 & 2032
6.3. Osteoarthritis: 2022 & 2032
6.4. Gout: 2022 & 2032
6.5. Multiple Sclerosis: 2022 & 2032
Chapter 7. Global Anti-inflammatory Peptides Market Size & Forecasts by Source (2022–2032)
7.1. Segment Dashboard
7.2. Animal Origin: 2022 & 2032
7.3. Plant Origin: 2022 & 2032
7.4. Microbial Origin: 2022 & 2032
Chapter 8. Global Anti-inflammatory Peptides Market Size & Forecasts by Route of Administration (2022–2032)
8.1. Segment Dashboard
8.2. Injections: 2022 & 2032
8.3. Oral: 2022 & 2032
8.4. Topical: 2022 & 2032
Chapter 9. Global Anti-inflammatory Peptides Market Size & Forecasts by Region (2022–2032)
9.1. North America Market
?9.1.1. U.S. Market
?9.1.2. Canada Market
9.2. Europe Market
?9.2.1. UK Market
?9.2.2. Germany Market
?9.2.3. France Market
?9.2.4. Spain Market
?9.2.5. Italy Market
?9.2.6. Rest of Europe Market
9.3. Asia Pacific Market
?9.3.1. China Market
?9.3.2. India Market
?9.3.3. Japan Market
?9.3.4. Australia Market
?9.3.5. South Korea Market
?9.3.6. Rest of Asia Pacific Market
9.4. Latin America Market
?9.4.1. Brazil Market
?9.4.2. Mexico Market
?9.4.3. Rest of Latin America Market
9.5. Middle East & Africa Market
?9.5.1. Saudi Arabia Market
?9.5.2. South Africa Market
?9.5.3. Rest of Middle East & Africa Market
Chapter 10. Competitive Intelligence
10.1. Key Company SWOT Analysis
?10.1.1. Amgen Inc.
?10.1.2. Novartis AG
?10.1.3. Pfizer Inc.
10.2. Top Market Strategies
10.3. Company Profiles
?10.3.1. Amgen Inc.
??10.3.1.1. Key Information
??10.3.1.2. Overview
??10.3.1.3. Financial (Subject to Data Availability)
??10.3.1.4. Product Summary
??10.3.1.5. Market Strategies
?10.3.2. Novartis AG
?10.3.3. Pfizer Inc.
?10.3.4. Teva Pharmaceutical Industries Ltd.
?10.3.5. Eli Lilly and Company
?10.3.6. AbbVie Inc.
?10.3.7. Bristol-Myers Squibb Company
?10.3.8. AstraZeneca PLC
?10.3.9. GlaxoSmithKline PLC
?10.3.10. Merck & Co., Inc.
?10.3.11. Sanofi S.A.
?10.3.12. F. Hoffmann-La Roche Ltd
?10.3.13. Takeda Pharmaceutical Company Limited
?10.3.14. BioCryst Pharmaceuticals, Inc.
?10.3.15. Regeneron Pharmaceuticals, Inc.
Chapter 11. Research Process
11.1. Data Mining
11.2. Analysis
11.3. Market Estimation
11.4. Validation
11.5. Publishing
11.6. Research Attributes



List of Figures

List of Figures
FIG 1. Research Methodology Flowchart
FIG 2. Market Estimation Techniques
FIG 3. Global Market Size: Historical vs. Forecast
FIG 4. Key Trends Shaping the Market
FIG 5. CAGR Outlook by Segment (2024–2032)
FIG 6. Porter’s Five Forces Analysis
FIG 7. PESTEL Analysis Summary
FIG 8. Value Chain Analysis
FIG 9. Market Share by Mechanism of Action (2023)
FIG 10. Market Share by Indication (2023)
FIG 11. Market Share by Source (2023)
FIG 12. Market Share by Route of Administration (2023)
FIG 13. Regional Snapshot: 2022 vs. 2032
FIG 14. North America Market Trend (2022–2032)
FIG 15. Europe Market Trend (2022–2032)
FIG 16. Asia Pacific Market Trend (2022–2032)
FIG 17. Latin America Market Trend (2022–2032)
FIG 18. Middle East & Africa Market Trend (2022–2032)
FIG 19. Competitive Positioning Map
FIG 20. AI-Enabled Peptide Discovery Workflow

List of Tables

List of Tables
TABLE 1. Global Anti-inflammatory Peptides Market, Report Scope
TABLE 2. Global Market Estimates & Forecasts by Region (2022–2032)
TABLE 3. Global Market Estimates & Forecasts by Mechanism of Action (2022–2032)
TABLE 4. Global Market Estimates & Forecasts by Indication (2022–2032)
TABLE 5. Global Market Estimates & Forecasts by Source (2022–2032)
TABLE 6. Global Market Estimates & Forecasts by Route of Administration (2022–2032)
TABLE 7. North America Market Estimates & Forecasts, 2022–2032
TABLE 8. U.S. Market Estimates & Forecasts by Segment, 2022–2032
TABLE 9. Canada Market Estimates & Forecasts by Segment, 2022–2032
TABLE 10. Europe Market Estimates & Forecasts, 2022–2032
TABLE 11. Asia Pacific Market Estimates & Forecasts, 2022–2032
TABLE 12. Latin America Market Estimates & Forecasts, 2022–2032
TABLE 13. Middle East & Africa Market Estimates & Forecasts, 2022–2032
TABLE 14. Competitive Landscape: Market Shares of Top 10 Companies (2023)
TABLE 15. R&D Expenditure by Leading Players (2022)
TABLE 16. Peptide Pipeline by Mechanism of Action (2023)
TABLE 17. Oral vs. Injectable Route Adoption Rates (2023)
TABLE 18. Regional Pricing and Reimbursement Comparison (2023)
TABLE 19. Clinical Trial Landscape by Indication (2023)
TABLE 20. Forecasted Impact of AI on Peptide Discovery (2024–2032)